Cabergoline|cas 81409-90-7|DC Chemicals

Cabergoline|cas 81409-90-7|DC Chemicals

Cabergoline, an ergot derivative, is a potent dopamine receptor agonist on D2 receptors.

Target: D2 Receptors

Cabergoline, an ergot derivative, is a potent dopamine receptor agonist on D2 receptors.

Product Name: Cabergoline|Cat No: DC9423|Cas: 81409-90-7|Molecule Formular: C26H37N5O2|Molecule Weight: 451.6043|Other names: Cabergoline

Cabergoline, an ergot derivative, is a potent dopamine receptor agonist on D2 receptors.
Cabergoline, an ergot derivative, is a potent dopamine receptor agonist on D2 receptors. Rat studies show cabergoline has a direct inhibitory effect on pituitary lactotroph cells. Treatment with cabergoline was not associated with increased prevalence of cardiac valves regurgitation in patients with HyperPRL. Mean cumulative dose of cabergoline was lower in patients with HyperPRL than that reported to be deleterious for patients with Parkinson's disease: hence, longer follow-up is necessary, particularly in patients receiving weekly doses > 3 mg.

For research only, not for human use!